The SRT-100™: Taking New Aim at Skin Cancer and Keloids
The SRT-100™ | Superficial Radiation Therapy
Better Treatment For More Patients
SRT Therapy is a low energy Superficial Radiation Therapy that goes no deeper than the thickness of the skin. It is a proven non-invasive procedure that has been used to treat non-melanoma skin cancer for over 50 years. Because the x-rays concentrate the Superficial Radiation Therapy dose on the skin surface, the treatment has several advantages over surgical procedures for skin cancer, and it reduces recurrence rates in keloids tremendously when performed following surgical excision.
SQUAMOUS CELL CARCINOMA FACTS:
- This is the second most common form of skin cancer.
- Squamous cell carcinoma often looks like scaly red patches, open sores, elevated growths with a central depression, or warts; they may crust or bleed.
- An estimated 700,000 cases of squamous cell carcinomas are diagnosed each year in the United States.
BASAL CELL CARCINOMA FACTS:
- Basal cell carcinoma is a slow-growing form of skin cancer.
- Basal cell carcinomas often look like open sores, red patches, pink growths, shiny bumps, or scars.
- There are an estimated 2.8 million cases of basal cell carcinoma diagnosed in the United States each year.
KELOID SCAR FACTS:
- A keloid is a growth of extra scar tissue where the skin has healed after an injury, piercing, tattoo, etc.
- Most skin injury types can contribute to keloid scarring. This includes acne scars, burns, chickenpox scars, ear piercing, scratches, surgical cuts or vaccination sites.
- The most effective treatment is external beam Superficial Radiation Therapy (SRT), which can achieve cure rates of up to 90+% when performed following surgical excision.
Sensus Healthcare is taking new aim at skin cancer and keloids. The SRT-100™ provides a painless, safe, and effective treatment option for basal cell carcinomas, squamous cell carcinomas, and keloid scars. Ask your dermatologist for more information on this revolutionary treatment, and visit our site to learn more!